EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Design, Synthesis, and Evaluation of Bis ‐Chalcones and Bis ‐Flavones as Selective COX ‐2 Inhibitors

Rui Pereira, Marisa Freitas, Alberto N Araújo, Vera L M Silva iD, Eduarda Fernandes iD

Chemical Biology & Drug Design · 2026

DOI: 10.1111/cbdd.70268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2026. Verfasst von Rui Pereira und 4 weiteren Autor:innen. Beteiligte Einrichtung: LAQV-REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Chalcones, Cyclooxygenase 2 Inhibitors, Drug Design, Cyclooxygenase 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past two decades, the search for safe and effective COX‐2 inhibitors has spurred extensive research on flavonoids. Within this context, synthetic flavonoid dimers have emerged as a promising subclass with potential anti‐inflammatory activity. To investigate whether dimerization enhances their potency and selectivity, novel A‐fused bis ‐chalcones and A‐fused bis ‐flavones were synthesized and evaluated for their inhibitory activity against isolated human COX‐1 and COX‐2 enzymes, as well as their effects on prostaglandin E 2 production in whole human blood. Interestingly, the most active compound identified was a monomeric chalcone sharing the same substitution pattern as the top‐performing bis ‐chalcone, suggesting that key structural features drive activity regardless of dimerization. While the dimeric nature of bis ‐chalcones did not enhance COX‐2 inhibition or selectivity in this study, these results provide valuable insights into structure–activity relationships. Furthermore, all active compounds against the isolated enzyme showed reduced potency in whole blood, possibly due to plasma protein binding limiting bioavailability. This study highlights the importance of rational design for further development of dimeric flavonoids, in particular strategies aimed at optimizing bioavailability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChalconesCyclooxygenase 2 InhibitorsDrug DesignCyclooxygenase 2FlavonesHumansStructure-Activity RelationshipCyclooxygenase 1DinoprostoneDimerization

Stichwörter der Autor:innen

bis‐chalconesbis‐flavonescyclooxygenase‐2enzyme inhibitionin vitro evaluationsynthesiswhole‐blood

Substanzen

ChalconesCyclooxygenase 2 InhibitorsCyclooxygenase 2FlavonesCyclooxygenase 1Dinoprostone

Autor:innen und Institutionen

  • LAQV-REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.
  • LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro, Portugal.

ORCID-Profile: Vera L M Silva, Eduarda Fernandes

Förderung

  • Fundação para a Ciência e a Tecnologia

Zitieren

APA

Pereira, R., Freitas, M., Araújo, A. N., Silva, V. L. M., & Fernandes, E. (2026). Design, Synthesis, and Evaluation of Bis ‐Chalcones and Bis ‐Flavones as Selective COX ‐2 Inhibitors. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70268

Vancouver

Pereira R, Freitas M, Araújo AN, Silva VLM, Fernandes E. Design, Synthesis, and Evaluation of Bis ‐Chalcones and Bis ‐Flavones as Selective COX ‐2 Inhibitors. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70268

BibTeX
@article{Pereira2026,
  author = {Pereira, Rui and Freitas, Marisa and Araújo, Alberto N and Silva, Vera L M and Fernandes, Eduarda},
  title = {Design, Synthesis, and Evaluation of Bis ‐Chalcones and Bis ‐Flavones as Selective COX ‐2 Inhibitors},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  doi = {10.1111/cbdd.70268}
}
Kostenlos starten →